TOKYO -- Taisho Pharmaceutical Holdings will be delisted following the successful completion of a tender offer from a company owned by a member of the founding family, the drugmaker announced Tuesday.
The tender offer by Tokyo company Otemon, owned by Shigeru Uehara, received more than 60.03 million shares, exceeding the minimum threshold and giving the buyer a 73% stake in Taisho.
